1. Home
  2. HAS vs HALO Comparison

HAS vs HALO Comparison

Compare HAS & HALO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

HAS

Hasbro Inc.

N/A

Current Price

$90.22

Market Cap

13.3B

ML Signal

N/A

Logo Halozyme Therapeutics Inc.

HALO

Halozyme Therapeutics Inc.

N/A

Current Price

$107.93

Market Cap

12.0B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
HAS
HALO
Founded
1923
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Recreational Games/Products/Toys
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
13.3B
12.0B
IPO Year
1994
2001

Fundamental Metrics

Financial Performance
Metric
HAS
HALO
Price
$90.22
$107.93
Analyst Decision
Strong Buy
Buy
Analyst Count
15
9
Target Price
★ $109.50
$99.56
AVG Volume (30 Days)
1.3M
★ 2.0M
Earning Date
10-20-2026
11-02-2026
Dividend Yield
★ 3.19%
N/A
EPS Growth
N/A
★ N/A
EPS
2.51
★ 3.11
Revenue
★ $5,365,900,000.00
$151,862,000.00
Revenue This Year
$7.54
$32.72
Revenue Next Year
$6.79
$10.61
P/E Ratio
★ $35.09
$36.16
Revenue Growth
★ 13.06
N/A
52 Week Low
$69.50
$61.23
52 Week High
$106.98
$116.85

Technical Indicators

Market Signals
Indicator
HAS
HALO
Relative Strength Index (RSI) 41.79 54.81
Support Level $84.12 $104.49
Resistance Level $89.20 $111.15
Average True Range (ATR) 2.02 3.04
MACD -0.04 -0.71
Stochastic Oscillator 33.89 42.53

Price Performance

Historical Comparison
HAS
HALO

About HAS Hasbro Inc.

Hasbro is a branded play company providing children and families around the world with entertainment offerings based on a world-class brand portfolio. From toys and games to television programming, motion pictures, and a licensing program, Hasbro reaches customers by leveraging its well-known brands such as Transformers, Peppa Pig, and Magic: The Gathering. The firm acquired EOne in 2019, bolting on popular family properties like Peppa Pig and PJ Masks, and has since divested noncore lines from the tie-up. Furthermore, the addition of Dungeons & Dragons Beyond in 2022 offers the firm access to around 20 million digital tabletop players.

About HALO Halozyme Therapeutics Inc.

Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. ENHANZE drug delivery technology was introduced with the proprietary enzyme rHuPH20, to facilitate the subcutaneous delivery of injected drugs and fluids, with the goal of improving the patient experience with rapid SC delivery and reduced treatment burden. The company's operations are based in the United States, with minimal long-lived assets located internationally.

Share on Social Networks: